ChiCTR2300070596 版本V1.0 版本创建时间2023/04/18 09:02:24 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2300070596 

最近更新日期:

Date of Last Refreshed on:

2023-04-18 09:00:55 

注册时间:

Date of Registration:

2023-04-18 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

微塑料暴露与男性精液质量的相关性研究及其生物标志物的探索

Public title:

The correlation between microplastics exposure and male semen quality and the exploration research of biomarkers

注册题目简写:

English Acronym:

研究课题的正式科学名称:

微塑料暴露与男性精液质量的相关性研究及其生物标志物的探索

Scientific title:

The correlation between microplastics exposure and male semen quality and the exploration research of biomarkers

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

刘伟嘉 

研究负责人:

刘楠 

Applicant:

Weijia Liu 

Study leader:

Nan Liu 

申请注册联系人电话:

Applicant telephone:

+86 15617836152

研究负责人电话:

Study leader's telephone:

+86 13688869875

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

l15617836152@163.com

研究负责人电子邮件:

Study leader's E-mail:

13688869875@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省深圳市龙岗区平湖街道福新路1号

研究负责人通讯地址:

广东省深圳市龙岗区平湖街道福新路1号

Applicant address:

No.1 Fuxin Road, Pinghu Street, Longgang District, Shenzhen,Guangdong Province,P.R.China

Study leader's address:

No.1 Fuxin Road, Pinghu Street, Longgang District, Shenzhen,Guangdong Province,P.R.China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

深圳大学附属华南医院

Applicant's institution:

South China Hospital of Shenzhen University

研究负责人所在单位:

深圳大学附属华南医院

Affiliation of the Leader:

South China Hospital of Shenzhen University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

HNLS-20221019001-A

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

深圳大学附属华南医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shenzhen University Affiliated South China Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2022-12-27 00:00:00

伦理委员会联系人:

孙海燕

Contact Name of the ethic committee:

Haiyan Sun

伦理委员会联系地址:

广东省深圳市龙岗区平湖街道福新路1号

Contact Address of the ethic committee:

No.1 Fuxin Road, Pinghu Street, Longgang District, Shenzhen,Guangdong Province,P.R.China

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 755 21583934

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

深圳大学附属华南医院

Primary sponsor:

South China Hospital of Shenzhen University

研究实施负责(组长)单位地址:

广东省深圳市龙岗区平湖街道福新路1号

Primary sponsor's address:

No.1 Fuxin Road, Pinghu Street, Longgang District, Shenzhen,Guangdong Province,P.R.China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

深圳

Country:

China

Province:

Guangdong

City:

Shenzhen

单位(医院):

深圳大学附属华南医院

具体地址:

广东省深圳市龙岗区平湖街道福新路1号

Institution
hospital:

South China Hospital of Shenzhen University

Address:

No.1 Fuxin Road, Pinghu Street, Longgang District, Shenzhen,Guangdong Province,P.R.China

经费或物资来源:

国家自然科学基金、深圳市科技创新项目

Source(s) of funding:

National Natural Science Foundation of China, Project of Shenzhen Science and Technology

Target disease:

Male Infertility

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

队列研究 

Study design:

Cohort study 

研究目的:

本研究通过探测男性精液质量以及微塑料的浓度,结合蛋白组学,探索微塑料暴露与男性不育之间的相关性;评估微塑料对人类健康的早期生物效应的可能生物标志物  

Objectives of Study:

This study explored the correlation between microplastics exposure and quality of semen by detecting the concentration of microplastics in the semen and combining with proteomics, and assessing the possible biomarkers for the early biological effects of microplastics on human health.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

(1)禁欲时间2~7天;
(2)要求具有精液常规检测信息、调查问卷信息填写完整、且精液常规检查后剩余精液量超过微塑料检测的最低要求;
(3)年龄18~45岁;
(4)近期未接触金属化学品、无放射史;
(5)自愿签署知情同意,并能积极配合者。

Inclusion criteria

(1) Abstinence time, 2-7 days
(2) Information on routine semen testing, completed questionnaires, and residual semen volume after routine semen testing were required to exceed the minimum requirements for microplastics testing.
(3) Age range 18-45 years
(4) No recent exposure to metallochemicals, no history of radiation.
(5)Voluntarily signed informed consent and able to actively cooperate.

排除标准:

(1) 问卷信息填写不完整者,超过30%的题目未填或未按题目要求作答;
(2)患生殖系统疾病(无精子症、隐睾、附睾炎、前列腺炎、性传播疾病、输精管切除史、精索静脉曲张等)、出生缺陷(Y染色体缺失)的人群;
(3)近期(近1个月内)或长期(连续3个月)服用过影响精液质量药物(补肾强精药)的人群:
(4) 患内分泌性疾病、心血管疾病者。
(5)合并癌症、血液系统疾病患者;
(6)合并肝、肾功能不全的患者;
(7)临床病例资料、实验室的检验检查结果不全者;

Exclusion criteria:

(1) Those whose questionnaire information was incomplete to fill in, more than 30% of the titles were either not filled in or did not respond to their title requirements;
(2) Those suffering from reproductive diseases (azoospermia, cryptorchidism, epididymitis, prostatitis, sexually transmitted diseases, history of vasectomy, varicocele, etc.), birth defects (Y chromosome deletion;
(3) Recent (within nearly 1 month) or long-term (3 consecutive months) intake of medications affecting semen quality (kidney tonic spermatogonia);
(4) Affected with endocrinopathies, cardiovascular diseases).
(5) Patients with comorbid cancer or hematological diseases;
(6) Patients with combined hepatic and renal dysfunction;
(7) Data on clinical cases, incomplete laboratory test results.

研究实施时间:

Study execute time:

From 2023-04-18 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-04-18 00:00:00 To 2023-10-31 00:00:00  

干预措施:

Interventions:

组别:

微塑料高暴露组(塑料制品厂工作5年以上职业暴露的男性一线作业工人)

样本量:

30

Group:

High MP exposure group (Male front-line workers with occupational exposure for more than 5 years in a plastic product factory)

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

微塑料中暴露组(普通城市中点外卖频次达到2次/周的普通上班族男性)

样本量:

30

Group:

Medium MP exposure group (Ordinary working men who order takeout twice a week in ordinary cities)

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

微塑料低暴露组(偏远农村交通不便利农村常住男人人口)

样本量:

30

Group:

Low MP exposure group (Remote rural transportation is not convenient rural permanent male population)

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

深圳 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

深圳大学附属华南医院 

单位级别:

三级 

Institution
hospital:

South China Hospital of Shenzhen University

Level of the institution:

Tertiary hospital

测量指标:

Outcomes:

指标中文名:

精液常规

指标类型:

主要指标

Outcome:

The routine examination of semen

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

精子活性氧

指标类型:

主要指标

Outcome:

Reactive Oxygen Species

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

线粒体膜电位

指标类型:

主要指标

Outcome:

Mitochondrial Membrane Potential

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

精子DNA碎片指数

指标类型:

主要指标

Outcome:

DNA Fragmentation Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

精液中的微塑料浓度

指标类型:

主要指标

Outcome:

Microplastic concentrations in semen

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

炎症细胞因子

指标类型:

主要指标

Outcome:

Inflammatory cytokines

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

精液

组织:

Sample Name:

semem

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 45 years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

科研团队成员通过便利采样收集受试者的精液样本。

Randomization Procedure (please state who generates the random number sequence and by what method):

The semen samples from the subjects will be collected by research team members through convenient sampling.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台ResMan (www.medresman.org)

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan (www.medresman.org)

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

利用问卷星进行问卷电子信息采集和管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Utilizing WJX for electronic information collection and management of questionnaires.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2023-04-18 09:00:55